A new role for Bcl-XL in fibrosis

In a paper published in Science Translational Medicine, researchers from Harvard Medical School and colleagues suggest that inhibiting the anti-apoptotic protein Bcl-XL could treat fibrosis and describe a cell-based assay to stratify scleroderma patients into Bcl-XL inhibitor responders

Read the full 389 word article

User Sign In